✦ LIBER ✦

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

✍ Scribed by Molina, Julian R.; Foster, Nathan R.; Reungwetwattana, Thanyanan; Nelson, Garth D.; Grainger, Andrew V.; Steen, Preston D.; Stella, Philip J.; Marks, Randolph; Wright, John; Adjei, Alex A.

Book ID: 122284593
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 228 KB
Volume: 85
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2014.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Saracatinib, an Inhi

A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non–Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium

✍ Laurie, Scott A.; Goss, Glenwood D.; Shepherd, Frances A.; Reaume, M. Neil; Nich 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 205 KB

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor

Phase II Clinical Trial of Chemotherapy-

Phase II Clinical Trial of Chemotherapy-Naive Patients >= 70 Years of Age Treated With Erlotinib for Advanced Non-Small-Cell Lung Cancer

✍ Jackman, D. M.; Yeap, B. Y.; Lindeman, N. I.; Fidias, P.; Rabin, M. S.; Temel, J 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 134 KB

O-158 A randomized phase II ECOG trial o

O-158 A randomized phase II ECOG trial of two dose levels of temsirolimus (CCI-779) in patients with extensive stage small cell lung cancer in remission after induction therapy

✍ Pandya, K.; Levy, D.; Hidalgo, M.; Cohen, R.; Lee, M.; Dancey, J.; Schiller, J.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

168 Experiences of pre-trial quality ass

168 Experiences of pre-trial quality assurance (QA) for the CONVERT trial. A multicentre randomised phase III trial for good performance status patients with limited stage small cell lung cancer

✍ Wilson, E.; Groom, N.; Lyn, E.; Miles, E.; Tsang, Y.; Faivre-Finn, C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

251 A randomized phase II trial of neoad

251 A randomized phase II trial of neoadjuvant chemotherapy followed by surgery versus surgery alone in patients with stage I, II and IIIA (N0) non-small cell lung cancer. Preliminary analysis

✍ Splinter, A.W.; Smit, E.; Postmus, P.; Kho, G.S.; Maat, A.P.W.M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 150 KB